Small vessel cutaneous vasculitis: subtypes and treatment - Part II

Small vessel cutaneous vasculitis refers to a group of disorders usually characterized by palpable purpura, caused by leukocytoclastic vasculitis of postcapillary venules. Vasculitis can range in severity from a self-limited single-organ disorder to a life-threatening disease with the prospect of multiple-organ failure. This group of diseases presents many challenges to the dermatologist, including classification and diagnosis, laboratory workup, treatment, and the need for careful follow-up. This article reviews the subtypes of small vessel cutaneous vasculitis and current treatment options; it also presents a comprehensive approach to diagnosing and treating the patient with suspected cutaneous and systemic vasculitis.

[1]  F. Saulsbury.  Clinical update: Henoch-Schönlein purpura , 2007, The Lancet.

[2]  J. Carlson,et al.  Cutaneous Vasculitis Update: Small Vessel Neutrophilic Vasculitis Syndromes , 2006, The American Journal of dermatopathology.

[3]  F. Locatelli,et al.  Predictors of outcome in Henoch-Schönlein nephritis in children and adults. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  C. Ferri,et al.  Cryoglobulinemic vasculitis , 2006, Current opinion in rheumatology.

[5]  L. Gibson,et al.  Primary cutaneous small vessel vasculitis: approach to diagnosis and treatment , 2006, International journal of dermatology.

[6]  J. Carlson,et al.  Cutaneous Vasculitis Update: Diagnostic Criteria, Classification, Epidemiology, Etiology, Pathogenesis, Evaluation and Prognosis , 2005, The American Journal of dermatopathology.

[7]  J. Stone,et al.  “Essential” cutaneous vasculitis: what every rheumatologist should know about vasculitis of the skin , 2001, Current opinion in rheumatology.

[8]  Schulze,et al.  Hypocomplementaemic urticarial vasculitis: successful treatment with cyclophosphamide–dexamethasone pulse therapy , 1998, British Journal of Dermatology.

[9]  M. Davis,et al.  Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis. , 1998, Journal of the American Academy of Dermatology.

[10]  W. Schmitt,et al.  Vasculitis in the seriously ill patient: diagnostic approaches and therapeutic options in ANCA-associated vasculitis. , 1998, Kidney international. Supplement.

[11]  A. Eiser,et al.  Sustained Dapsone-Induced Remission of Hypocomplementemic Urticarial Vasculitis , 1997, Angiology.

[12]  H. Jasin,et al.  Vasculitis and lymphoproliferative diseases. , 1996, Seminars in arthritis and rheumatism.

[13]  E. R. Mcfadden,et al.  Hypocomplementemic Urticarial Vasculitis Syndrome: Clinical and Serologic Findings in 18 Patients , 1995, Medicine.

[14]  D. Mehregan,et al.  Urticarial vasculitis: a histopathologic and clinical review of 72 cases. , 1992, Journal of the American Academy of Dermatology.

[15]  S. Jones,et al.  IgG autoantibody to the collagen-like region of Clq in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus, and 6 other musculoskeletal or rheumatic diseases. , 1992, The Journal of rheumatology.

[16]  C. Cockerell,et al.  Noninfectious inflammatory skin diseases in HIV-infected individuals. , 1991, Dermatologic clinics.

[17]  E. E. Sahn,et al.  Follicular accentuation of leukocytoclastic vasculitis in an HIV-seropositive man. Report of a case and review of the literature. , 1991, Journal of the American Academy of Dermatology.

[18]  W. Buchanan,et al.  Serum sickness-like illness and leukocytoclastic vasculitis after intravenous streptokinase. , 1991, Journal of the American Academy of Dermatology.

[19]  M. Rybojad,et al.  Urticarial vasculitis associated with a monoclonal IgM gammopathy: Schnitzler's syndrome , 1990, The British journal of dermatology.

[20]  D. Wagner,et al.  PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes , 1989, Cell.

[21]  R. Barlow,et al.  Necrotizing folliculitis in AIDS‐related complex , 1987, The British journal of dermatology.

[22]  M. Hammond,et al.  Hypocomplementemic urticarial vasculitis syndrome responsive to dapsone. , 1986, Journal of the American Academy of Dermatology.

[23]  L. Gibson,et al.  Henoch-Schönlein vasculitis: direct immunofluorescence study of uninvolved skin. , 1986, Journal of the American Academy of Dermatology.

[24]  S. Green,et al.  The Koebner phenomenon in anaphylactoid purpura. , 1986, Cutis.

[25]  J. C. Wiles,et al.  Urticarial vasculitis treated with colchicine. , 1985, Archives of dermatology.

[26]  W. Su,et al.  Clinical and histopathologic spectrum of necrotizing vasculitis. Report of findings in 101 cases. , 1985, Archives of dermatology.

[27]  P. Kohler,et al.  The hypocomplementemic urticarial-vasculitis syndrome: therapeutic response to hydroxychloroquine. , 1984, The Journal of allergy and clinical immunology.

[28]  J. Jorizzo,et al.  Dermatologic conditions reported in patients with rheumatoid arthritis. , 1983, Journal of the American Academy of Dermatology.

[29]  R. Winkelmann,et al.  The clinical and histopathologic spectrums of urticarial vasculitis: study of forty cases. , 1982, Journal of the American Academy of Dermatology.

[30]  J. Clauvel,et al.  Biologic and clinical significance of cryoglobulins. A report of 86 cases. , 1974, The American journal of medicine.

[31]  F. C. Mcduffie,et al.  Hypocomplementemia with cutaneous vasculitis and arthritis. Possible immune complex syndrome. , 1973, Mayo Clinic proceedings.

[32]  R. Good.  Disorders of the Immune System , 1967 .